Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism

Structure

Volumn 4, Issue 9, 1996, Pages 1105-1114

  Nam, Hyun Joo ^a   Haser, Wayne G ^a   Roberts, Thomas M ^a   Frederick, Christin A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bcr Abl; protein kinase; SH2 SH3 domains; X ray crystallography

Indexed keywords

EID: 0030587518     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(96)00116-5     Document Type: Article

References (52)

1. Lemmon, M.A. & Schlessinger, J. (1994). Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci. 19, 459-493.
2. Wang, J.Y.J. (1993). Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Devel. 3, 35-43.
3. Goff, S.P., Gilba, E., Witte, O.N. & Baltimore, D. (1980). Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell 22, 777-785.
4. Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. (1985). Fused transcript of the abl and bcr genes in chronic myelogenous leukemia. Nature 315, 550-554.
5. Mes-Masson, A.-M., McLaughlin, J., Daley, G.Q., Paskind, M. & Witte, O.N. (1986). Overlapping cDNA clones define the complete coding region for the p210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 83, 9768-9772.
6. Daley, G.Q., Van Etten, R.A. & Baltimore, D. (1990). Induction of chronic myelogenous leukemia in mice by the p210bcr/ abl gene of the Philadelphia chromosome. Science 247, 824-830.
7. Jackson, P. & Baltimore, D. (1989). N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8, 449-456.
8. Franz, W.M., Berger, P. & Wang, J.Y.J. (1989). Deletion of an N-terminal regulatory domain of the c-Abl tyrosine kinase activates its oncogenic potential. EMBO J. 8, 137-147.
9. Pawson, T. (1992). SH2 and SH3 domains. Curr. Opin. Struct. Biol. 2, 432-437.
10. Schlessinger, J. (1994). SH2/SH3 signaling proteins. Curr. Opin. Genet. Dev. 4, 25-30.
11. Birge, R.B. & Hanafusa, H. (1993). Closing in on SH2 specificity. Science 262, 1522-1524.
12. Viguera, A.R., Arrondo, J.L.R., Musacchio, A., Saraste, M. & Serrano, L. (1994). Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. Biochemistry 33, 10925-10933.
13. Cicchetti, P., Mayer, B.J., Thiel, G. & Baltimore, D. (1992). Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257, 803-806.
14. Ren, R., Mayer, B.J., Ciccheti, P. & Baltimore, D. (1993). Identification of a ten-amino acid proline-rich SH3 binding site. Science 259, 1157-1161.
15. Mayer, B. & Baltimore, D. (1994). Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell Biol. 14, 2883-2894.
16. Mayer, B.J., Jackson, P.K. & Baltimore, D. (1991). The noncatalytic Src homology region 2 segment of Abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Proc. Natl. Acad. Sci. USA 88, 627-631.
17. Songyang, Z., et al., & Cantley, L.C. (1993). SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778.
18. Mayer, B., Jackson, P., Van Etten, R. & Baltimore, D. (1992). Point mutations in the Abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol. Cell Biol. 12, 609-618.
19. Superti-Furga, G., Fumagalli, S., Koegl, M., Coutneidge, S.A. & Draetta, G. (1993). Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 12, 2625-2634.
20. Panchamoorthy, G., et al., & Band, H. (1994). Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn. Mol. Cell Biol. 14, 6372-6385.
21. Musacchio, A., Saraste, M. & Wilmanns, M. (1994). High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline rich peptides. Nat. Struct. Biol. 1, 546-551.
22. Overduin, M., Rios, C., Mayer, B., Baltimore, D. & Cowburn, D. (1992). Three-dimensional solution structure of the Src homology 2 domain of c-Abl. Cell 70, 697-704.
23. Kuriyan, J. & Cowburn, D. (1993). Structures of SH2 and SH3 domains. Curr. Opin. Struct. Biol. 3, 828-837.
24. Musacchio, A., Wilmanns, M. & Saraste, M. (1994). Structure and function of the SH3 domain. Prog. Biophys. Mol. Biol. 61, 283-297.
25. Waksman, G., Shoelson, S.E., Pant, N., Cowburn, D. & Kuriyan, J. (1993). Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72, 779-790.
26. Eck, M.J., Shoelson, S.E. & Harrison, S.C. (1993). Recognition of a high-affinity phosphotyrosyl peptide by the Src-homology-2 domain of p56 lck. Nature 362, 87-91.
27. Yu, H., Chen, J.K., Feng, S., Dalgarno, D.C., Brauer, A.W. & Schreiber, S.L. (1994). Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76, 933-945.
28. Musacchio, A., Noble, M., Pauptit, R., Wierenga, R. & Saraste, M. (1992). Crystal structure of a Src homology 3 (SH3) domain. Nature 359, 851-855.
29. Lee, C.H., et al., & Kuriyan, J. (1994). Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure 2, 423-38.
30. Hatada, M.H., et al., & Karas, J.L. (1995). Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 377, 32-38.
31. Eck, M., Atwell, S.K., Shoelson, S.E. & Harrison, S.C. (1994). Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature 368, 764-769.
32. Maignan, S., Guilloteau, J.-P., Fromage, N., Arnoux, B., Becquart, J. & Ducruix, A. (1995). Crystal structure of the mammalian Grb2 adaptor. Science 268, 291-293.
33. Gosser, Y.Q., Zheng, J., Overduin, M., Mayer, B. & Cowburn, D. (1995). The solution structure of Abl SH3 and its relationship to SH2 in the SH(32) construct. Structure 3, 1075-1086.
34. Ernst, T.J., Slattery, K.E. & Griffin, J.D. (1994). p210Bcr/Abl and p160v-abl induce an increase in the tyrosine phosphorylation of p93c-fes. J. Biol. Chem. 269, 5764-5769.
35. Dai, Z. & Pendergast, A.M. (1995). Abi-2, a novel SH3-contaning protein interacts with the Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev. 9, 2569-2582.
36. Shi, Y., Alin, K. & Goff, S.P. (1995). Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev. 9, 2583-2597.
37. Margolis, B., et al., & Schlessinger, J. (1990). The tyrosine phosphorylated carboxy terminus of the EG F receptor is a binding site for GAP and PLC-γ. EMBO J. 9, 4375-4380.
38. Pendergast, A.M., Muller, A., Havlik, M., Maru, Y. & Witte, O.N. (1991). Bcr sequences essential for transformation by the Bcr-Abl oncogene bind to the Abl SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66, 161-171.
39. Lemmon, M.A., Ladbury, J.E., Mandiyan, V., Zhou, M. & Schlessinger, J. (1994). Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2. J. Biol. Chem. 269, 31653-31658.
40. Cussac, D., Frech, M. & Chardin, P. (1994). Binding of the Grb2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domains for Sos proline-rich motifs. EMBO J. 13, 4011-4021.
41. Rosen, M.K., Yamazaki, T., Gish, G.D., Kay, C.M., Pawson, T. & Kay, L.E. (1995). Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374, 477-479.
42. Otwinowski, Z. (1993). Oscillation data reduction program. In Data Collection and Processing, Proceedings of the CCP4 Study Weekend. (Sawyer, L., Isaacs, N. & Bailey, S., eds), pp. 56-62, SERC Daresbury Laboratory, Warrington, UK.
43. Waksman, G., et al., & Kuriyan, J. (1992). Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358, 646-653.
44. Navaza, J. (1994). AMoRe: An automated package for molecular replacement. Acta. Cryst. A 50, 157-163.
45. Brünger, A.T. (1990). Extension of molecular replacement: a new search strategy based on Patterson correlation refinement. Acta. Cryst. A 46, 46-57.
46. Brünger, AT. (1993) X-PLOR: Version 3.1. A system for Crystallography and NMR. Yale University Press, New Haven, CT, USA.
47. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. A 47, 110-119.
48. Ramachandran, G.M. & Sasisekharan, V. (1968). Conformations of polypeptides and proteins. Adv. Protein Chem. 23, 283-437.
49. Simanis, V. & Lane, D.P. (1985). An immunoaffinity purification procedure for SV40 large T antigen. Virology 144, 88-100.
50. Druker, B.J., Mamon, H.J. & Roberts, T.M. (1989). Oncogenes, proteins, and signal transduction. N. Engl. J. Med. 321, 1383-1391.
51. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946-950.
52. Nicolls, A., Bharadwaj, R. & Honig, B. (1993). GRASP: graphical representation and analysis of surface properties. Biophys. J. 64, 166-170.